Literature DB >> 12447102

Low-grade gliomas in adults.

Jeremy H Rees1.   

Abstract

PURPOSE OF REVIEW: This paper aims to summarize the current thinking about the management of adult supratentorial low-grade gliomas. These are well differentiated primary brain tumours that typically develop in young adults. Their biological behaviour is poorly understood but the majority of these tumours grow slowly, infiltrate surrounding normal brain, and show an intrinsic tendency to undergo malignant transformation to high-grade gliomas. Surgery and radiotherapy are the main treatment options, but their precise role and timing are controversial. RECENT
FINDINGS: Resective surgery is at best regarded as a practice option because there is a paucity of good quality evidence to show that extent of resection correlates with survival. Radiotherapy prolongs progression-free survival but not overall survival and may lead to long-term cognitive deficits, although not as widespread as had previously been thought. A minority of tumours with oligodendroglial differentiation are chemosensitive and this correlates with allelic loss of chromosomes 1p and 19q. New imaging and molecular techniques, in particular gene microarray studies, are providing more information about these tumours, although they have yet to have a significant impact on clinical management.
SUMMARY: The best management of low-grade gliomas is still unknown but advances in molecular genetics and imaging are improving our ability to prognosticate and follow the natural history of these tumours. Copyright 2002 Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  2002        PMID: 12447102     DOI: 10.1097/01.wco.0000044760.39452.71

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  9 in total

Review 1.  Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective.

Authors:  A Brodbelt
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

2.  Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.

Authors:  Pietro Ivo D'Urso; Oscar Fernando D'Urso; Carlo Storelli; Giuseppe Catapano; Cosimo Damiano Gianfreda; Antonio Montinaro; Antonella Muscella; Santo Marsigliante
Journal:  J Neurooncol       Date:  2010-12-03       Impact factor: 4.130

Review 3.  Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Authors:  Jill M Abrigo; Daniel M Fountain; James M Provenzale; Eric K Law; Joey Sw Kwong; Michael G Hart; Wilson Wai San Tam
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22

Review 4.  New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity--a review.

Authors:  Hugues Duffau
Journal:  J Neurooncol       Date:  2006-04-11       Impact factor: 4.130

5.  Magnetic resonance image registration and subtraction in the assessment of minor changes in low grade glioma volume.

Authors:  S E J Connor; R Gunny; T Hampton; R O'gorman
Journal:  Eur Radiol       Date:  2004-07-14       Impact factor: 5.315

6.  Multiparametric characterization of grade 2 glioma subtypes using magnetic resonance spectroscopic, perfusion, and diffusion imaging.

Authors:  Wei Bian; Inas S Khayal; Janine M Lupo; Colleen McGue; Scott Vandenberg; Kathleen R Lamborn; Susan M Chang; Soonmee Cha; Sarah J Nelson
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

Review 7.  Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults.

Authors:  Lynn S Ashby; William R Shapiro
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

8.  Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.

Authors:  P S Murphy; L Viviers; C Abson; I J Rowland; M Brada; M O Leach; A S K Dzik-Jurasz
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

9.  Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy.

Authors:  Roland Roelz; David Strohmaier; Ramazan Jabbarli; Rainer Kraeutle; Karl Egger; Volker A Coenen; Astrid Weyerbrock; Peter C Reinacher
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.